ZYUS Life Sciences Inc is a biopharmaceutical company based in Saskatoon, Canada, that specializes in the development and commercialization of cannabinoid-based therapeutics and phyto-therapeutic compounds. Founded in 2018, the company focuses on providing innovative medical solutions aimed at alleviating suffering for patients dealing with chronic diseases, treatment side effects, and age-related conditions. ZYUS strives to promote cannabinoids as standard medical treatments, emphasizing overall well-being rather than solely addressing physical ailments. As a licensed producer and distributor of medical cannabis in Canada, ZYUS aims to accelerate the adoption of phytotherapeutics in healthcare, utilizing scientific research to support its commitment to improve patient care and quality of life.
Phoenix Canada Oil Company Limited, established in 1944 and based in Toronto, Canada, specializes in the exploration and development of oil and natural gas properties, primarily in Western Canada. The company manages a portfolio of investments and holds minority interests in mature gas fields. In recent years, Phoenix has shifted its focus towards developing clean energy solutions, particularly in water-derived hydrogen technologies. Through its subsidiary, Phoenix International Energy, Inc., the company possesses worldwide development rights to a patented hydrogen gas generation technology and is collaborating with academic institutions in Canada to advance this technology to commercial viability. Additionally, Phoenix is involved in research and development efforts with universities and government bodies to create synthetic hydrocarbon fuels derived from water-based hydrogen, leveraging C1 chemistry.
Revon Systems
Acquisition in 2019
Revon Systems is a developer of a platform for connecting physicians and patients. It offers a web platform that allows physicians to deliver care to patients remotely, specializes in helping patients with cardiovascular and lung conditions to self-manage signs and symptoms, intervene early on health decline that enables patients to manage their health and improve quality of life.
Ehave - Platform
Acquisition in 2019
Ehave - Platform contains components specifically designed to be used by medical cannabis patients to efficiently gather and verify patient-reported outcomes and experiences, evaluate treatment progress, enhance patient engagement and improve data modeling.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.